Renal fibrosis: novel insights into mechanisms and therapeutic targets - PubMed (original) (raw)
Review
Renal fibrosis: novel insights into mechanisms and therapeutic targets
Peter Boor et al. Nat Rev Nephrol. 2010 Nov.
Abstract
Renal fibrosis is the common end point of virtually all progressive kidney diseases. Renal fibrosis should not be viewed as a simple and uniform 'scar', but rather as a dynamic system that involves extracellular matrix components and many, if not all, renal and infiltrating cell types. The involved cells exhibit enormous plasticity or phenotypic variability-a fact that we are only beginning to appreciate. Only a detailed understanding of the underlying mechanisms of renal fibrosis can facilitate the development of effective treatments. In this Review, we discuss the most recent advances in renal, or more specifically, tubulointerstitial fibrosis. Novel mechanisms as well as potential treatment targets based on different cell types are described. Problems that continue to plague the field are also discussed, including specific therapeutic targeting of the kidney, the development of improved diagnostic methods to assess renal fibrosis and the shortcomings of available animal models.
Similar articles
- Renal fibrosis: insights into pathogenesis and treatment.
el Nahas AM, Muchaneta-Kubara EC, Essawy M, Soylemezoglu O. el Nahas AM, et al. Int J Biochem Cell Biol. 1997 Jan;29(1):55-62. doi: 10.1016/s1357-2725(96)00119-7. Int J Biochem Cell Biol. 1997. PMID: 9076941 Review. - Renal tubulointerstitial fibrosis: common but never simple.
Hewitson TD. Hewitson TD. Am J Physiol Renal Physiol. 2009 Jun;296(6):F1239-44. doi: 10.1152/ajprenal.90521.2008. Epub 2009 Jan 14. Am J Physiol Renal Physiol. 2009. PMID: 19144691 Review. - Bone marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model.
Xing L, Song E, Yu CY, Jia XB, Ma J, Sui MS, Wang MA, Gao X. Xing L, et al. J Cell Biochem. 2019 Jun;120(6):9737-9746. doi: 10.1002/jcb.28254. Epub 2018 Dec 7. J Cell Biochem. 2019. PMID: 30525227 - Mechanisms of tubulointerstitial fibrosis.
Zeisberg M, Neilson EG. Zeisberg M, et al. J Am Soc Nephrol. 2010 Nov;21(11):1819-34. doi: 10.1681/ASN.2010080793. Epub 2010 Sep 23. J Am Soc Nephrol. 2010. PMID: 20864689 Review. - Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.
Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, Nordström V, Kopp-Schneider A, Hielscher T, Nelson PJ, Schaefer F, Porubsky S, Fliser D, Arnold B, Gröne HJ. Federico G, et al. JCI Insight. 2016 Jan 21;1(1):e84916. doi: 10.1172/jci.insight.84916. JCI Insight. 2016. PMID: 27699213 Free PMC article.
Cited by
- Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG, An HJ, Gu H, Kim YA, Han SM, Park KK. Gwon MG, et al. J Mol Med (Berl). 2021 Sep;99(9):1265-1277. doi: 10.1007/s00109-021-02087-x. Epub 2021 May 24. J Mol Med (Berl). 2021. PMID: 34031696 - Ameliorative Effects of Osthole on Experimental Renal Fibrosis in vivo and in vitro by Inhibiting IL-11/ERK1/2 Signaling.
Wu F, Zhao Y, Shao Q, Fang K, Dong R, Jiang S, Lu F, Luo J, Chen G. Wu F, et al. Front Pharmacol. 2021 May 13;12:646331. doi: 10.3389/fphar.2021.646331. eCollection 2021. Front Pharmacol. 2021. PMID: 34054526 Free PMC article. - XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress.
Zhang J, Zhao Y, Gong N. Zhang J, et al. Antioxidants (Basel). 2023 Oct 30;12(11):1933. doi: 10.3390/antiox12111933. Antioxidants (Basel). 2023. PMID: 38001786 Free PMC article. Review. - Shen Qi Wan-Containing Serum Alleviates Renal Interstitial Fibrosis via Restraining Notch1-Mediated Epithelial-Mesenchymal Transition.
Chen H, Zhou X, Yang Y, Feng Y. Chen H, et al. Evid Based Complement Alternat Med. 2023 Feb 6;2023:3352353. doi: 10.1155/2023/3352353. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36793762 Free PMC article. - The pathological significance of dipeptidyl peptidase-4 in endothelial cell homeostasis and kidney fibrosis.
Kanasaki K. Kanasaki K. Diabetol Int. 2016 Aug 3;7(3):212-220. doi: 10.1007/s13340-016-0281-z. eCollection 2016 Sep. Diabetol Int. 2016. PMID: 30603266 Free PMC article.
References
- Am J Pathol. 2008 Jun;172(6):1491-9 - PubMed
- Histochem Cell Biol. 2008 Aug;130(2):247-62 - PubMed
- Kidney Int. 2010 Jul;78(2):191-9 - PubMed
- J Immunol. 2009 Nov 15;183(10):6733-43 - PubMed
- J Am Soc Nephrol. 2002 Apr;13(4):910-917 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical